Article citationsMore>>

E. Gullotti and Y. Yeo, “Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery,” Molecular Pharmaceutics, Vol. 6, No. 4, 2009, pp. 1041-1051. doi:10.1021/mp900090

has been cited by the following article:

• TITLE: Evaluation of Biological Effects of Nanosystems of Directed Transport in Experiments in Vivo and Their Application Possibilities in Anti-Tumor Therapy

  AUTHORS: Vasyl F. Chekhun, Lesia A. Naleskina, Liudmila Z. Polishchuk, Igor M. Todor, Dmytro V. Demash, Natalia Yu. Lukianova

  KEYWORDS: Oncology; Nanocomposite; Static Magnetic Field; Cisplatin; Anti-Tumor Activity; Guerin Carcinoma

  JOURNAL NAME: Advances in Nanoparticles, Vol.2 No.2, May 25, 2013

  ABSTRACT: The aim of the investigations was to evaluate benefits of the directed transport system - a nanocomposite, based on cisplatin and magnetite combined with local action of constant magnetic field on the tumor, in experiments in vivo in animals with transplantable Guerin carcinoma. Animals were divided into 5 groups according to the type of agent. We showed that nanocomposite in combination with static magnetic field exercises more prominent anti-tumor activity than cisplatin alone. It should be noted that regardless of the therapeutic agent, in Guerin carcinoma we observed